603087 甘李藥業
按盤價 
48.790 +3.840 (+8.543%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.752 | 3.346 | -4.450 | 15.207 | 17.080 |
| 總資產報酬率 ROA (%) | 2.526 | 3.047 | -4.096 | 14.270 | 15.845 |
| 投入資產回報率 ROIC (%) | 2.734 | 3.318 | -4.406 | 15.039 | 13.624 | 邊際利潤分析 |
| 銷售毛利率 (%) | 73.450 | 73.259 | 76.300 | 89.034 | 90.879 |
| 營業利潤率 (%) | 25.808 | 12.089 | -33.223 | 47.035 | 43.217 |
| 息稅前利潤/營業總收入 (%) | 22.756 | 8.720 | -39.525 | 42.057 | 42.979 |
| 淨利潤/營業總收入 (%) | 22.732 | 13.046 | -25.669 | 40.220 | 36.608 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 38.973 | 98.437 | 88.691 | 93.766 | 97.753 |
| 價值變動淨收益/利潤總額(%) | 57.365 | 14.835 | -1.187 | 5.049 | 1.416 |
| 營業外收支淨額/利潤總額(%) | 0.441 | -2.987 | 2.335 | -0.171 | -0.514 | 償債能力分析 |
| 流動比率 (X) | 8.289 | 7.985 | 6.967 | 14.150 | 14.541 |
| 速動比率 (X) | 7.045 | 6.872 | 6.169 | 12.809 | 13.337 |
| 資產負債率 (%) | 8.161 | 8.301 | 9.628 | 6.321 | 5.986 |
| 帶息債務/全部投入資本 (%) | -1.283 | -1.134 | -1.156 | -0.949 | -- |
| 股東權益/帶息債務 (%) | -7,742.145 | -8,756.858 | -8,562.875 | -10,432.315 | -18,529.749 |
| 股東權益/負債合計 (%) | 1,125.315 | 1,104.609 | 938.613 | 1,482.069 | 1,570.667 |
| 利息保障倍數 (X) | -7.186 | -2.889 | 7.177 | -8.588 | -2,516.401 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 51.659 | 38.649 | 116.694 | 87.751 | 0.000 |
| 存貨周轉天數 (天) | 466.848 | 389.502 | 576.622 | 520.223 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
